The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Reversal following new 20-day high

Biosyent Inc closed lower Friday, dropping $0.04 or 0.47% to $8.40 after setting a new 20-day high. Over the last five days, shares have gained 0.96% and 20.00% year to date. Shares have outperformed the S&P TSX by 9.33% during the last year.

Key company metrics

  • Trailing P/E31.04×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.27
Updated September 23 2:44 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+23.56%

Based on its net profit margin of 23.56%, Biosyent Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.67%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue4445
Total other revenue--------
Total revenue4445
Gross profit3334
Total cost of revenue1111
Total operating expense3333
Selling / general / administrative2222
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income1111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1112
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment0000
Diluted weighted average shares15141414
Diluted EPS excluding extraordinary itemsvalue per share0.070.070.050.08
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.070.070.050.08